Dialysis Transition Patterns of Chronic Kidney Disease Patients With and Without Heart Failure

Mitchell E Flagg1, Simran K Bhandari2, Katherine J Pak3

  • 1Department of Internal Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA.

Mayo Clinic Proceedings
|February 19, 2025
PubMed

Insights

Patients with chronic kidney disease (CKD) and heart failure (HF) experience suboptimal dialysis initiation, including more inpatient starts and central venous catheter use. These findings suggest tailored management strategies for CKD patients with HF are needed.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Chronic kidney disease (CKD) and heart failure (HF) are common comorbidities.
  • The transition to maintenance dialysis for CKD patients requires careful management.
  • Heart failure impacts CKD progression and dialysis initiation patterns.

Purpose of the Study:

  • To compare dialysis transition patterns between CKD patients with and without HF.
  • To investigate differences in inpatient dialysis initiation, dialysis initiation eGFR, and central venous catheter (CVC) use.
  • To identify potential disparities in care for CKD patients with comorbid HF.

Main Methods:

  • A cross-sectional study of CKD patients initiating maintenance dialysis between 2007-2018.
  • Patients were categorized based on the presence and type of heart failure.
  • Poisson regression was used to assess the association between HF and dialysis initiation/access patterns.

Main Results:

  • 37% of 6812 CKD patients initiating dialysis had HF.
  • Patients with HF had higher rates of inpatient dialysis initiation (18.5% vs 9.6%) and CVC use (58.5% vs 51.9%).
  • CKD patients with HF initiated dialysis at a higher mean eGFR (11.3 vs 9.4 mL/min/1.73 m²).

Conclusions:

  • CKD patients with HF exhibit higher rates of suboptimal dialysis initiation.
  • These include more frequent inpatient dialysis starts and central venous catheter placement.
  • Findings highlight the need for distinct management strategies for CKD patients with HF nearing dialysis.
Abstract

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
252
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
334
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
60
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
500